• Trichostatin A (TSA): HDAC Inhibitor Protocol and Lab Guidan

  2026-06-01

  Trichostatin A (TSA) enables controlled epigenetic modulation by reversibly inhibiting HDAC enzymes, facilitating studies on histone acetylation and cell cycle regulation in cancer research. It is best suited for in vitro and in vivo oncology workflows requiring reproducible induction of cell cycle arrest and differentiation. TSA should not be used in workflows demanding aqueous solubility or long-term solution stability.

• 740 Y-P: Precision PI 3-Kinase Activator for Cellular Resear

  2026-06-01

  740 Y-P empowers researchers with reproducible activation of the PI3K/AKT pathway, enabling quantitative control in vesicular trafficking, neuronal survival, and apoptosis assays. Its robust solubility and validated workflow parameters, sourced from APExBIO, provide a strong foundation for advanced cell signaling research.

• Intranasal Epinephrine in Dogs: Pharmacokinetics and Heart R

  2026-05-31

  This study rigorously evaluates intranasal epinephrine delivery in dogs, contrasting its pharmacokinetics and cardiovascular effects with standard intramuscular injection. The work identifies intranasal administration as a promising alternative route, with rapid systemic absorption and potentially reduced adverse heart rate responses, informing both translational research and future clinical strategies.

• Androgen Receptor Antagonism Alters Myeloid Cell Immunity in

  2026-05-30

  This study reveals that enzalutamide, an androgen receptor antagonist, paradoxically enhances tumor-promoting functions of myeloid cells by suppressing mitochondrial respiration and increasing immunosuppression, thereby accelerating tumor progression. The findings reshape our understanding of antiandrogen therapy resistance, emphasizing the influence of the tumor microenvironment beyond direct tumor cell effects.

• Arrb2-Driven M2 Polarization Mitigates Hepatic IRI via 6-ket

  2026-05-29

  This study elucidates how Arrb2 expression in hepatocytes promotes M2 macrophage polarization through upregulation of the metabolite 6-ketoLCA, resulting in reduced hepatic ischemia–reperfusion injury (IRI) in mouse models. The findings define a distinct immunometabolic axis relevant to improving liver transplantation outcomes and suggest new directions for targeted therapeutic strategies.

• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine for Src Kinase

  2026-05-29

  Leverage 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) as a high-fidelity negative control to dissect Src kinase signaling pathways with unmatched clarity. This research use only chemical from APExBIO streamlines specificity validation, troubleshooting, and reproducibility in advanced vascular and cellular signaling research.

• Bradykinin B2 Receptors Inhibit Peristalsis in Guinea Pig Il

  2026-05-28

  This study provides the first direct evidence that bradykinin B2 receptors mediate inhibition of the peristaltic reflex in the guinea pig ileum. By differentiating B1 and B2 receptor roles using selective pharmacological agents, the findings clarify key mechanisms in enteric neurotransmission and offer a foundation for further research on gastrointestinal and hypertension pathways.

• Hematoxylin and Eosin Staining Kit: Technical Workflow Guide

  2026-05-28

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides ready-to-use solutions for reliable tissue morphology visualization in research histology. It streamlines the staining of paraffin-embedded, frozen tissue sections, and cytological samples, but it is not intended for diagnostic or clinical applications.

• Cinoxacin: Quinolone Antibiotic Workflows for Gram-Negative

  2026-05-27

  Cinoxacin, a quinolone antibiotic, streamlines experimental workflows targeting Gram-negative bacteria, especially in urinary tract infection and resistance studies. This article delivers actionable, evidence-backed protocols, comparative insights, and troubleshooting strategies, equipping laboratories to maximize reproducibility and translational value.

• Agatoxin-IVA-Sensitive Calcium Channels in Cardiac Vagal Neu

  2026-05-27

  This study identifies agatoxin-IVA-sensitive voltage-dependent calcium channels as crucial mediators of both presynaptic and postsynaptic nicotinic activation in cardiac vagal neurons. The findings clarify the channel subtypes responsible for cholinergic modulation of heart rate, offering mechanistic insights that inform neurophysiology and cardiac regulation research.

• ZIF8 Nanoplatform Enables Imaging-Guided Synergistic TNBC Th

  2026-05-26

  Li et al. (2026) developed a folic acid–PEG–modified ZIF8 nanoplatform that delivers ciprofloxacin for targeted, ultrasound-guided therapy in triple-negative breast cancer. By integrating sonodynamic, chemotherapeutic, and immune-modulating actions, this multifunctional system achieves precise tumor targeting and enhanced antitumor efficacy.

• Fludarabine: Mechanistic Powerhouse for Translational Oncolo

  2026-05-26

  This article positions Fludarabine as a linchpin DNA synthesis inhibitor for translational oncology, synthesizing advanced mechanistic insights with strategic workflow guidance. Building on breakthrough findings in lymphodepleting chemotherapy and immunotherapy synergy, we detail how Fludarabine unlocks experimental innovation in leukemia and multiple myeloma research. The discussion integrates numerical data, protocol advice, and APExBIO’s product advantages, while differentiating itself by mapping the future of immune-oncology workflows using this proven purine analog prodrug.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Pr

  2026-05-25

  DiI (DiIC18(3)) is a lipophilic orange fluorescent probe optimized for robust plasma membrane labeling in live and fixed cells. It is best suited for workflows requiring high-contrast membrane staining, neuronal tracing, and cell migration assays, but should not be used in aqueous-based protocols or for targeting intracellular organelles.

• IWP-2: Strategic Wnt Pathway Inhibition for Translational Im

  2026-05-25

  Explore how the small-molecule Wnt production inhibitor IWP-2 empowers translational researchers to dissect and modulate Wnt/β-catenin signaling with unprecedented precision. This article synthesizes mechanistic insight, workflow optimization, and a forward-looking vision to guide cancer and disease modelers, drawing on both recent molecular discoveries and APExBIO’s innovative product standards.

• SU6656 Src Tyrosine Kinases Inhibitor: Mechanisms & Benchmar

  2026-05-24

  SU6656 is a potent, selective Src tyrosine kinases inhibitor with verified activity in both cancer research and ex vivo platelet production. Its mechanistic specificity and translational utility are supported by peer-reviewed studies and product data. Protocol-driven use of SU6656 enables workflow cost reduction and radiotherapy sensitization.

449 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page